Clinical trial NCT06168435: e-IMPAQc Systematic Assessment of Patient Reported Outcomes in Cancer Care
Official title: e-IMPAQc Implementation and Evaluation of a Mobile Application for the Systematic Assessment of Patient and Caregiver Reported Outcomes in Quebec Across the Cancer Continuum (eIMPAQc)
Study type: INTERVENTIONAL
Overall status: ENROLLING_BY_INVITATION
Phase: NA
Conditions: Cancer
Keywords: ePRO
Lead sponsor: St. Mary's Research Center, Canada
Sponsor class: OTHER
First posted: 2023-12-13
Enrollment: 500
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NON_RANDOMIZED
Intervention model: SEQUENTIAL
Primary purpose: OTHER

Brief summary: Purpose: The Electronic Implementation of Patient and Caregiver Reported Outcomes across cancer centres in Quebec project, or e-IMPAQc, was launched in 2017. e-IMPAQc's goal is to actively engage patients, their caregivers, healthcare professionals (HCPs), managers, policy makers, researchers and IT personnel to co-develop, implement, and evaluate an evidence-informed electronic patient-reported outcomes (e-PRO) screening and management program across Quebec.

Methods: e-IMPAQc built on the Improving Patient Experience and Health Outcomes Collaborative (iPEHOC) project, the first initiative in the province to implement e-PRO screening and was rolled out in three phases. e-IMPAQc has five main components: 1) primary and secondary standardized e-PRO questionnaires and algorithm; 2) summary report for clinicians with alert system; 3) summary report for patients, with tailored notifications regarding symptom severity; 4) self-management fact sheets library; and 5) clinical dashboard. Phase 1 included initiating change management and the co-development of the e-PRO algorithm with patients, their caregivers, HCPs, managers, policy makers, researchers and IT personnel (herein collectively referred as stakeholders) across seven cancer centres. The iPEHOC algorithm was used as a starting point given its successful implementation in one of the participating cancer centres for several years. Phase 1 also included feasibility work to establish a caregiver-reported outcomes (CROs) algorithm as well as the identification and configuration of appropriate electronic platforms on which to house e-IMPAQc. In Phase 2 the focus was on preparing for imminent implementation through workflow mapping and putting in place implementation support (e.g., site coordinators). A pilot of e-IMPAQc (excluding CROs) was also undertaken at one of the participating centres. In Phase 3, e-IMPAQc is being sequentially rolled out to as many cancer centres as possible and then evaluated. Qualitative and quantitative methods are used to document the process of implementation, patient and caregiver, and knowledge transfer (KT) outcomes.


Eligibility criteria: Inclusion Criteria:

* Receiving cancer care at designated center

Exclusion Criteria:

* Unable to speak English or French
* Unable to use email and internet

Primary outcomes:
measure: Symptom severity
timeFrame: Baseline, 4 months
measure: Patient perception of communication with health care team
timeFrame: Baseline, 4 months
measure: Patient activation
timeFrame: Baseline, 4 months
measure: Quality of life
timeFrame: Bsaseline,4 months
measure: Emergency room visits
timeFrame: In the 18 months following consent
measure: Survival
timeFrame: In the 18 months following consent
measure: Feasibility of using the eIMPAQc ePRO system in cancer care centres
timeFrame: Throughout the implementation period, over the course of each participants' 4-6 month follow-up period
measure: Acceptability of using the eIMPAQc ePRO system in cancer care centres
timeFrame: Throughout the implementation period, over the course of each participants' 4-6 month follow-up period
measure: Satisfaction
timeFrame: 4 months
Secondary outcomes:
Other outcomes:
Locations:
city: Montreal
country: Canada
facility: St. Mary's Research Centre
state: Quebec
Study officials:
References: